Vinaikra may cause renal impairment, so in use it is recommended to regularly monitor the glomerular filtration rate and other indicators, and pay attention to adverse reactions and contraindications. Venekra is mainly used for the treatment of acute myeloid leukemia, small lymphocytic lymphoma and other lymphohematopoietic malignancies. During the use of the drug, due to tumor lysis syndrome and other factors, may cause renal function injury, in the use of the drug is recommended to regularly monitor creatinine clearance, blood uric acid and other indicators, at the same time in the first time before the use of the drug, it is recommended to be assessed by a clinician according to the condition of the appropriate supplementation of water, as well as anti-hyperuricemia drugs. In addition, in the use of severe hematopenia, infection, etc. need to be promptly disposed of or suspend the use of the drug. The drug is contraindicated in pregnancy. The drug needs to be used under the guidance of an experienced physician, and unauthorized use is prohibited.